Psychiatry and Behavioral Sciences

Frederick K. Goodwin, MD

  

        Frederick K. Goodwin, MD

  
SPEAKER BIO

Frederick K. Goodwin, M.D., is Clinical Professor of Psychiatry at The George Washington University and Director of the University’s Center on Neuroscience, Medical Progress, and Society. Dr. Goodwin’s research focuses on bipolar disorder, major depression and suicide. His policy interests include the impact of changing patterns of health care on quality and innovation in medicine.

Dr. Goodwin is a founding partner of Best Practice, a consulting firm providing expertise to pharmaceutical and biotech companies and managed care organizations worldwide. Dr. Goodwin’s role encompasses many facets including public policy analysis, patient and physician education, and the development of research protocols. A Best Practice study Dr. Goodwin headed found that lithium was significantly more effective than another widely used mood stabilizer protecting against suicide among 26,000 bipolar I patients.

Dr. Goodwin is a former Director of the National Institute of Mental Health (NIMH).   Prior to that, he held a Presidential appointment as head of the Alcohol, Drug Abuse, and Mental Health Administration.  A physician-scientist specializing in psychiatry and psychopharmacology, Dr. Goodwin served from 1981 to 1988 as NIMH Scientific Director and chief of Intramural Research.  He joined the NIMH in 1965 and has become an internationally recognized authority in the research and treatment of major depression and bipolar illness.  For example, he was first to report the antidepressant effects of lithium in a controlled study.

A graduate of Georgetown Univ., Dr. Goodwin received his M.D. from St. Louis Univ., and took his psychiatric residency at the Univ. of North Carolina in Chapel Hill.  He is a Member of the Institute of Medicine of the National Academy of Sciences and a Fellow of the ACNP.  He serves or has served on the editorial boards of key scientific journals, including the Archives of General Psychiatry, The Journal of Clinical Psychopharmacology, Bipolar Disorders, The World Journal of Biological Psychiatry, and was a founder and co-editor in chief of Psychiatry Research.

Dr. Goodwin is a recipient of the major research awards in his field including the Hofheimer Prize from the American Psychiatric Association, the A.E. Bennett Award from The Soc. Of Biological Psychiatry, the Psychopharmacology Research Award from the American Psychological Association, the International Anna-Monika Prize for Research in Depression, the Edward A. Strecker Award, the Falcone Prize from NARSAD, the McAlpin Research Award from the National Mental Health Association, the Distinguished Service Award from NAMI, the Research Award from the American Foundation for Suicide Prevention and the Lifetime Achievement Award from International Review Of Bipolar Disorders  He was the first recipient of the Psychiatrist of the Year (“Best Teacher in Psychiatry”) from Psychiatric Times, and the first recipient of the Fawcett Humanitarian Award of the Depression and Bipolar Support Alliance (DBSA). He has also received the Public Service Award from the Federation of American Societies for Experimental Biology (FASEB), and, in 2007, the Hope Award from DBSA.   In 1998 he was elected and served as President of the Psychiatric Research Society.

The author of over 460 publications, Dr. Goodwin (with K. R. Jamison, Ph.D.) wrote Manic-Depressive Illness, the first psychiatric text to win the Best Medical Book award from the Association of American Publishers. The second edition, Manic Depressive Illness: Bipolar Disorders and Recurrent Depression, was published in March 2007 and for this he was awarded the 2008 Best Medical Book award from the American Medical Writers Association, (Physicians Category). He is one of five psychiatrists on the Current Contents list of the most frequently cited scientists in the world and one of twelve psychiatrists listed in The Best Doctors in the U.S.

In addition to his work at The George Washington University Medical Center and his private practice, Dr. Goodwin served as host of the award winning weekly public radio show, The Infinite Mind from 1998 through 2005, and subsequently as guest host. The show went out of production in 2007 due to a lack of ongoing funding.

  
      OBJECTIVES                                                                                                                                                               
       At the completion of this session, the participant will be able to:
       

1.  Discuss the concept of the affective spectrum and appreciate cyclicity as an important parameter independent of polarity.
2.  Choose the best stabilizer regimen for long-term prophylaxis based on the individual clinical picture.
3.  Manage the treatment of breakthrough depression in bipolar patients on maintenance medication.
4.  Recognize those depressed patients who are at the greatest risk of being destabilized by antidepressants without a mood
     stabilizer.

       

« back to November calendar

 
 
 

© 2014  Medical University of South Carolina | Disclaimer